ParkinI. Travel to a hot climate as a trigger for NMS. Australasian Psychiatry2010; 18: 72–
2.
KellamAM. The neuroleptic malignant syndrome, so-called. A survey of the world literature. British Journal of Psychiatry1987; 150: 752–759–
3.
LevinsonDFSimpsonGM. Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the ‘neuroleptic malignant syndrome’. Archives of General Psychiatry1986; 43: 839–848–
4.
SesslerDI. Thermoregulatory defense mechanisms. Critical Care Medicine2009; 37: S203–S210–
5.
Martin-LatryKGoumyMPLatryP. Psychotropic drugs use and risk of heat-related hospitalisation. European Psychiatry2007; 22: 335–338–
6.
DematteJEO'MaraKBuescherJ. Near-fatal heat stroke during the 1995 heat wave in Chicago. Annals of Internal Medicine1998; 129: 173–181–
7.
CarterR3rdCheuvrontSNSawkaMN. A case report of idiosyncratic hyperthermia and review of US Army heat stroke hospitalizations. Journal of Sports Rehabilitaton2007; 16: 238–243–
8.
NoakesTDugasJDugasL. Body temperatures during three long-distance polar swims in water of 0–3°C. Journal of Thermal Biology2009; 34: 23–31–
9.
TorlineRL. Extreme hyperpyrexia associated with central anticholinergic syndrome. Anesthesiology1992; 76: 470–471–
10.
HillAB. The environment and disease: association or causation?Proceedings of the Royal Society of Medicine1965; 58: 295–300–
11.
TakuboHHaradaTHashimotoT. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism & Related Disorders2003; 9(Suppl. 1): S31–S41–
12.
PatelRJSaylorTWilliamsSRClarkRF. Prevalence of autonomic signs and symptoms in antimuscarinic drug poisonings. Journal of Emergency Medicine2004; 26: 89–94–
13.
IsbisterGKBuckleyNAWhyteIM. Serotonin toxicity: a practical approach to diagnosis and treatment. Medical Journal of Australia2007; 187: 361–365–